Roche

Introduction
Roche is a leading global pharmaceutical and diagnostics company, founded in 1896 in Switzerland. The company is widely recognized for its focus on biotechnology, personalized healthcare, and innovative diagnostics. Roche is the world’s largest biotech company, with a strong presence in oncology, immunology, infectious diseases, ophthalmology, and neuroscience. Its diagnostics division also makes Roche a leader in in-vitro diagnostics and tissue-based cancer tests.

Mission and Vision

Mission: To improve patients’ lives with innovative medicines and diagnostic tools.
Vision: To pioneer personalized healthcare solutions that deliver the right treatment to the right patient at the right time.

Products and Services

Pharmaceuticals: Innovative therapies in oncology, immunology, neuroscience, and rare diseases.
Diagnostics: In-vitro diagnostics, molecular diagnostics, and laboratory solutions.
Biotech Specialization: Monoclonal antibodies and targeted therapies.
COVID-19 Response: Diagnostic testing kits and therapeutic research.
Subsidiaries: Genentech (US-based biotech pioneer) and Chugai Pharmaceutical (Japan).

Growth and Innovation
Roche is known for its pioneering role in biotechnology and personalized healthcare, integrating diagnostic testing with tailored treatments. It was one of the first to invest heavily in biologics, which now represent a significant share of its portfolio. With Genentech as part of its group, Roche leads the biotech field in cancer research and advanced therapies.

Global Impact
With operations in over 100 countries, Roche serves millions of patients worldwide. Its oncology medicines have significantly advanced cancer treatment outcomes. The diagnostics division plays a critical role in global healthcare systems by providing reliable tools for disease detection and monitoring. Roche also invests in sustainability, committing to reducing its environmental footprint while expanding access to innovative healthcare solutions.